Does RAVULIZUMAB-CWVZ Cause Diplopia? 294 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 294 reports of Diplopia have been filed in association with RAVULIZUMAB-CWVZ. This represents 2.9% of all adverse event reports for RAVULIZUMAB-CWVZ.
294
Reports of Diplopia with RAVULIZUMAB-CWVZ
2.9%
of all RAVULIZUMAB-CWVZ reports
0
Deaths
17
Hospitalizations
How Dangerous Is Diplopia From RAVULIZUMAB-CWVZ?
Of the 294 reports, 17 (5.8%) required hospitalization.
Is Diplopia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RAVULIZUMAB-CWVZ. However, 294 reports have been filed with the FAERS database.
What Other Side Effects Does RAVULIZUMAB-CWVZ Cause?
Fatigue (1,472)
Asthenia (727)
Headache (639)
Drug ineffective (570)
Off label use (451)
Muscular weakness (422)
Dyspnoea (414)
Malaise (353)
Haemoglobin decreased (346)
Myasthenia gravis (338)
What Other Drugs Cause Diplopia?
ESOMEPRAZOLE (585)
SIMVASTATIN (560)
PREGABALIN (556)
HYDROCHLOROTHIAZIDE (544)
BISOPROLOL (541)
ADALIMUMAB (531)
FINGOLIMOD (505)
LEVOTHYROXINE (473)
APIXABAN (471)
ATORVASTATIN (396)
Which RAVULIZUMAB-CWVZ Alternatives Have Lower Diplopia Risk?
RAVULIZUMAB-CWVZ vs REBAMIPIDE
RAVULIZUMAB-CWVZ vs REBETOL
RAVULIZUMAB-CWVZ vs REBIF
RAVULIZUMAB-CWVZ vs REBOXETINE
RAVULIZUMAB-CWVZ vs RECLAST